Certified by Founder Lodge
OncoResponse
United States - Seattle, Washington
START UP
1 Disclosed Funding Rounds $14,000,000
0 Participating Investments
-
Founded date
2016
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
OncoResponse is a clinical stage, privately held immuno-oncology biotech company developing cancer immunotherapies using clues from the immune systems of elite cancer responders. In a broad s
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| May, 19 ,2023 | Unknown | $14,000,000 |
ARCH Venture Partners
Canaan
InterVest Co., LTD
Takeda Ventures, Inc.
3B Future Health Fund I & II
Bering Capital
RiverVest Venture Partners
Wildcat Discovery Technologies
Leaps by Bayer
ResearchHub
DNTOX
Helex | $3,500,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
catalyx space | $5,400,000 | (Nov 4, 2025)
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)